MED Intelligent Ultrasound Group Plc

TIDMIUG

Intelligent Ultrasound Group PLC

18 May 2023

Intelligent Ultrasound Group plc

(the "Group" or the "Company")

Mello investor conference

Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to clinic' ultrasound company, specialising in artificial intelligence (AI) software and simulation announces that Stuart Gall, Chief Executive Officer, will be presenting at the Mello2023 investor conference on Tuesday, 23 May to be held at the Clayton Hotel Chiswick, Chiswick High Road, London, W4 5RY.

For further information and tickets (use code SHME100 for complimentary entry on Tuesday) for the Mello2023 conference, please visit the event website at https://melloevents.com/mello2023tickets/

For further information, please contact:

 
Intelligent Ultrasound Group                                                     www. intelligentultrasound.com 
 plc 
Stuart Gall, CEO                                                                       Tel: +44 (0)29 2075 6534 
Helen Jones, CFO 
 
 
Cenkos Securities - Nominated Advisor                                                  Tel: +44 (0)20 7397 8900 
 and Broker 
Giles Balleny / Max Gould (Corporate 
 Finance) 
Michael Johnson / Julian Morse 
 (Sales) 
 
 
Walbrook PR                                    Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com 
Anna Dunphy                                                                            Mob: +44 (0)7876 741 001 
 
 

ABOUT INTELLIGENT ULTRASOUND GROUP

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to clinic' ultrasound companies, specialising in real-time hi-fidelity virtual reality simulation for the ultrasound training market ('classroom') and artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market ('clinic'). Based in Cardiff in the UK and Atlanta in the USA, the Group has two revenue streams:

Simulation

Real-time hi-fidelity ultrasound education and training through simulation. Our main products are the ScanTrainer obstetrics and gynaecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Paediatric training simulator. To date c. 1500 simulators have been sold to over 750 medical institutions around the world.

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more accessible using our proprietary ScanNav ultrasound image analysis technology. Current products on the market utilising this technology are GE HealthCare's SonoLyst software that is incorporated in their Voluson Expert 22 and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies ultrasound image interpretation by providing the user with real-time AI-based anatomy highlighting for a range of ultrasound guided regional anaesthesia procedures; and NeedleTrainer that teaches real-time ultrasound-guided needling and incorporates ScanNav Anatomy PNB.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAEDLFFXELLBBL

(END) Dow Jones Newswires

May 18, 2023 02:00 ET (06:00 GMT)

Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Dec 2024 to Jan 2025

Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Jan 2024 to Jan 2025